Monoclonal gammopathy of renal significance Clinical Trials

Delta Trials indexes 4 clinical trials for Monoclonal gammopathy of renal significance in its publicly accessible dataset. Of these, 2 enrolling participants at this time and 1 trial have reached completion. This research takes place spanning 20 research sites around the world. An additional 1 trial are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.